Testing effectiveness (Phase 2)Study completedNCT02437253
What this trial is testing
Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
Who this might be right for
Mucopolysaccharidosis Type IMucopolysaccharidosis Type IIMucopolysaccharidosis Type VI
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 2